Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 20 studies | 32% ± 14% | |
astrocyte | 15 studies | 35% ± 17% | |
oligodendrocyte precursor cell | 8 studies | 28% ± 12% | |
GABAergic neuron | 7 studies | 39% ± 18% | |
interneuron | 6 studies | 37% ± 19% | |
epithelial cell | 6 studies | 34% ± 22% | |
ciliated cell | 6 studies | 30% ± 20% | |
glutamatergic neuron | 5 studies | 48% ± 17% | |
pericyte | 4 studies | 21% ± 5% | |
macrophage | 4 studies | 28% ± 7% | |
neuron | 4 studies | 35% ± 7% | |
amacrine cell | 4 studies | 26% ± 9% | |
endothelial cell of lymphatic vessel | 4 studies | 21% ± 4% | |
fibroblast | 4 studies | 22% ± 6% | |
smooth muscle cell | 4 studies | 21% ± 4% | |
glomerular endothelial cell | 3 studies | 29% ± 7% | |
GABAergic interneuron | 3 studies | 23% ± 10% | |
granule cell | 3 studies | 22% ± 4% | |
GABAergic amacrine cell | 3 studies | 19% ± 4% | |
glycinergic amacrine cell | 3 studies | 22% ± 1% | |
endothelial cell of vascular tree | 3 studies | 26% ± 10% | |
ependymal cell | 3 studies | 44% ± 14% | |
myofibroblast cell | 3 studies | 23% ± 4% | |
adipocyte | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 8 studies | 33% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 4153.37 | 2637 / 2642 | 100% | 30.21 | 705 / 705 |
ovary | 100% | 5923.43 | 180 / 180 | 99% | 13.31 | 427 / 430 |
kidney | 100% | 3567.26 | 89 / 89 | 99% | 15.51 | 891 / 901 |
thymus | 100% | 5596.69 | 653 / 653 | 99% | 14.45 | 598 / 605 |
breast | 100% | 7193.33 | 459 / 459 | 97% | 12.20 | 1086 / 1118 |
uterus | 100% | 8002.33 | 170 / 170 | 96% | 17.68 | 440 / 459 |
prostate | 100% | 3956.46 | 245 / 245 | 95% | 7.18 | 479 / 502 |
adrenal gland | 100% | 2329.66 | 258 / 258 | 95% | 8.22 | 219 / 230 |
skin | 97% | 2241.87 | 1755 / 1809 | 94% | 12.59 | 445 / 472 |
lung | 100% | 4593.96 | 577 / 578 | 86% | 13.24 | 993 / 1155 |
esophagus | 99% | 3568.80 | 1435 / 1445 | 70% | 6.94 | 128 / 183 |
pancreas | 74% | 1173.37 | 243 / 328 | 94% | 10.08 | 168 / 178 |
bladder | 100% | 3157.81 | 21 / 21 | 63% | 6.89 | 316 / 504 |
intestine | 94% | 4184.41 | 907 / 966 | 23% | 1.63 | 123 / 527 |
stomach | 87% | 2050.93 | 311 / 359 | 28% | 2.75 | 80 / 286 |
adipose | 100% | 7322.58 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9497.18 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 3209.99 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 95% | 2137.90 | 816 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 10.71 | 74 / 80 |
tonsil | 0% | 0 | 0 / 0 | 91% | 8.48 | 41 / 45 |
muscle | 89% | 1571.35 | 711 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 5.73 | 22 / 29 |
liver | 4% | 52.93 | 10 / 226 | 12% | 0.92 | 48 / 406 |
peripheral blood | 13% | 287.27 | 123 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0036211 | Biological process | protein modification process |
GO_0009064 | Biological process | glutamine family amino acid metabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0072590 | Molecular function | N-acetyl-L-aspartate-L-glutamate ligase activity |
GO_0072591 | Molecular function | citrate-L-glutamate ligase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | RIMKLB |
Protein name | Beta-citrylglutamate synthase B (EC 6.3.1.17) (N-acetyl-aspartylglutamate synthetase B) (NAAG synthetase B) (NAAGS) (EC 6.3.2.41) (Ribosomal protein S6 modification-like protein B) Ribosomal modification protein rimK like family member B Alternative protein RIMKLB |
Synonyms | KIAA1238 FAM80B |
Description | FUNCTION: Catalyzes the synthesis of beta-citryl-L-glutamate and N-acetyl-L-aspartyl-L-glutamate. Beta-citryl-L-glutamate is synthesized more efficiently than N-acetyl-L-aspartyl-L-glutamate. . |
Accessions | ENST00000541044.5 F5GZH5 ENST00000535829.6 [Q9ULI2-1] ENST00000619374.4 [Q9ULI2-2] L8EB22 ENST00000538135.5 [Q9ULI2-1] ENST00000544257.5 [Q9ULI2-2] ENST00000539923.5 ENST00000537189.1 ENST00000357529.7 [Q9ULI2-1] Q9ULI2 F5H552 F5H3V4 |